Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
24.35
+0.20 (0.83%)
At close: Sep 17, 2025, 4:00 PM EDT
23.70
-0.65 (-2.67%)
After-hours: Sep 17, 2025, 7:35 PM EDT
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $67.83 million as of September 17, 2025. Its market cap has increased by 269.84% in one year.
Market Cap
67.83M
Enterprise Value
43.35M
1-Year Change
269.84%
Ranking
Category
Stock Price
$24.35
Market Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has decreased from $245.32M to $67.83M, a decrease of -72.35%. That is a compound annual growth rate of -15.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 67.28M | 159.65% |
| Dec 31, 2024 | 25.91M | -15.83% |
| Dec 29, 2023 | 30.78M | -70.81% |
| Dec 30, 2022 | 105.47M | -38.35% |
| Dec 31, 2021 | 171.08M | -24.02% |
| Dec 31, 2020 | 225.18M | -35.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |